von BOETTICHER Rechtsanwälte Partnerschaftsgesellschaft mbB is experienced in pharmaceutical law with a focus on pharmaceutical advertising law. The team is well versed in the enforcement of claims in interim injunction proceedings pertaining to pharmaceuticals, medical devices and cosmetics. Claudia Böhm regularly represents clients in pharmaceutical advertising law proceedings and is experienced in the vaccines segment. Anselm Brandi-Dohrn is a key contact for contract drafting, including license and cooperation agreements.

Legal 500 Editorial commentary

Key clients

  • Aceto GmbH
  • Acino-Gruppe
  • Bavarian Nordic GmbH
  • Belano Medical AG
  • Betterguards GmbH
  • CellAct Pharma GmbH
  • Cellbricks GmbH
  • EVER Neuro Pharma GmbH (AT); EVER Pharma GmbH (DE); EVER Valinject GmbH (DE)
  • Gilead Sciences GmbH
  • LEO Pharma GmbH
  • Lipotype GmbH
  • Madaus & Lauscher GmbH
  • Nekonal S.a.r.l. (Lux)
  • Sanochemia Pharmazeutika GmbH
  • Sedana Medical AB (publ)

Work highlights

  • Advising and representing the EVER Group in setting up pharmaceutical production for drugs and medical devices at locations at home and abroad.
  • Advising Gilead Sciences GmbH in competition law disputes with ViiV Healthcare GmbH regarding new scientific data.

Other key lawyers

Claudia Böhm, Anselm Brandi-Dohrn, Holger Alt